How to Trip Rapid Review

Step 1: Select articles relevant to your search (remember the system is only optimised for single intervention studies)

Step 2: press

Step 3: review the result, and maybe amend the or if you know better! If we're unsure of the overall sentiment of the trial we will display the conclusion under the article title. We then require you to tell us what the correct sentiment is.

156 results for

HIV related Myelopathy

by
...
Latest & greatest
Alerts

Export results

Use check boxes to select individual results below

SmartSearch available

Trip's SmartSearch engine has discovered connected searches & results. Click to show

21. HIV-1 Associated CNS Complications (Treatment) (Treatment)

, neoplastic processes secondary to immunodeficiency or those related to treatment include: Immune Reconstitution Inflammatory Syndrome of the CNS (CNS-IRIS) [ , ] Kaposi sarcoma Fungal infections (eg, , Penicillium marneffei encephalitis) [ ] Tuberculous meningitis encephalitis In addition, HIV-infected patients are susceptible to the same neurologic diseases as patients without infection. In AIDS, a clinical presentation often cannot be explained with a single diagnosis. New-onset neurologic (...) . Other organisms, such as the JC or SV40 viruses that cause PML, may be activated directly by HIV gene products. The likelihood of a particular neurologic syndrome correlates with the clinical stage of HIV infection as reflected by viral load, immune response, and CD4 + lymphocyte counts. This, in turn, is related to the severity of immunodeficiency and autoimmunity and to serum and tissue cytokine levels. Entrance of HIV into the CNS occurs early in the course of infection, likely within days

2014 eMedicine.com

22. Dementia Due to HIV Disease (Treatment)

inhibited and are more prone to HIV-related risk behavior (eg, unprotected intercourse), and they therefore pose a greater risk of transmission of the virus. In addition to HIV itself, other causes of neurologic complications in HIV-infected individuals include opportunistic infections, tumors, and antiretroviral drugs. Other neurologic complications that arise from primary HIV infection include vacuolar myelopathy, peripheral neuropathies, and polymyositis. For other discussions of HIV infection, see (...) . HIV-1 encephalopathy and AIDS dementia complex. Multinucleated giant cells, as shown here, are a hallmark of HIV encephalitis and harbor the virus. Image contributed by Dr Beth Levy, Saint Louis University School of Medicine, St Louis, Missouri. Previous Next: Antiretroviral and Other Therapies Currently, highly active antiretroviral therapy (HAART) is the cornerstone of treatment for HIV-related cognitive disorders. Aggressive early treatment of patients with HIV disease with antiviral

2014 eMedicine.com

23. Dementia Due to HIV Disease (Follow-up)

inhibited and are more prone to HIV-related risk behavior (eg, unprotected intercourse), and they therefore pose a greater risk of transmission of the virus. In addition to HIV itself, other causes of neurologic complications in HIV-infected individuals include opportunistic infections, tumors, and antiretroviral drugs. Other neurologic complications that arise from primary HIV infection include vacuolar myelopathy, peripheral neuropathies, and polymyositis. For other discussions of HIV infection, see (...) . HIV-1 encephalopathy and AIDS dementia complex. Multinucleated giant cells, as shown here, are a hallmark of HIV encephalitis and harbor the virus. Image contributed by Dr Beth Levy, Saint Louis University School of Medicine, St Louis, Missouri. Previous Next: Antiretroviral and Other Therapies Currently, highly active antiretroviral therapy (HAART) is the cornerstone of treatment for HIV-related cognitive disorders. Aggressive early treatment of patients with HIV disease with antiviral

2014 eMedicine.com

24. HIV-1 Associated Opportunistic Infections: CNS Toxoplasmosis (Follow-up)

study in Mexico city with 320 patients AIDS patients, the main conditions related to HIV/AIDS were brain toxoplasmosis (42%), cerebral cryptococcosis (28%), tuberculous meningitis (8.7%), lymphoma (non-Hodgkin) (3.75%), acute HIV infection (3.4%), and AIDS dementia complex (3%). [ ] The widespread use of antiretroviral treatment has decreased the incidence of toxoplasmic encephalitis. As an example, among HIV-infected patients in the United States, the annual number of toxoplasmosis-related (...) with sustained response to anti-retroviral therapy. Clin Microbiol Infect . 2006 Jul. 12(7):666-71. . Behbahani R, Moshfeghi M, Baxter JD. Therapeutic approaches for AIDS-related toxoplasmosis. Ann Pharmacother . 1995 Jul-Aug. 29(7-8):760-8. . AAN Quality Standards Subcommittee. Evaluation and management of intracranial mass lesions in AIDS. Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology . 1998 Jan. 50(1):21-6. . Klepser ME, Klepser TB. Drug treatment of HIV

2014 eMedicine.com

25. HIV-1 Encephalopathy and AIDS Dementia Complex (Follow-up)

, these patients are likely to be less inhibited and are more prone to HIV-related risk behavior (eg, unprotected intercourse), and they therefore pose a greater risk of transmission of the virus. In addition to HIV itself, other causes of neurologic complications in HIV-infected individuals include opportunistic infections, tumors, and antiretroviral drugs. Other neurologic complications that arise from primary HIV infection include vacuolar myelopathy, peripheral neuropathies, and polymyositis. For other (...) of treatment for HIV-related cognitive disorders. Aggressive early treatment of patients with HIV disease with antiviral medications and early suppression of viral replication prevents most of the devastating consequences of HIV dementia. [ ] Several studies have shown that early and aggressive treatment of HIV infection decreases the rate of dementia from greater than 50% to 10%. Multiple studies have shown that patients on HAART show partial reversals of neuropsychological deficits and significant

2014 eMedicine.com

26. HIV-1 Associated CNS Complications (Follow-up) (Follow-up)

, neoplastic processes secondary to immunodeficiency or those related to treatment include: Immune Reconstitution Inflammatory Syndrome of the CNS (CNS-IRIS) [ , ] Kaposi sarcoma Fungal infections (eg, , Penicillium marneffei encephalitis) [ ] Tuberculous meningitis encephalitis In addition, HIV-infected patients are susceptible to the same neurologic diseases as patients without infection. In AIDS, a clinical presentation often cannot be explained with a single diagnosis. New-onset neurologic (...) . Other organisms, such as the JC or SV40 viruses that cause PML, may be activated directly by HIV gene products. The likelihood of a particular neurologic syndrome correlates with the clinical stage of HIV infection as reflected by viral load, immune response, and CD4 + lymphocyte counts. This, in turn, is related to the severity of immunodeficiency and autoimmunity and to serum and tissue cytokine levels. Entrance of HIV into the CNS occurs early in the course of infection, likely within days

2014 eMedicine.com

27. HIV-1 Associated Cerebrovascular Complications (Follow-up)

, neoplastic processes secondary to immunodeficiency or those related to treatment include: Immune Reconstitution Inflammatory Syndrome of the CNS (CNS-IRIS) [ , ] Kaposi sarcoma Fungal infections (eg, , Penicillium marneffei encephalitis) [ ] Tuberculous meningitis encephalitis In addition, HIV-infected patients are susceptible to the same neurologic diseases as patients without infection. In AIDS, a clinical presentation often cannot be explained with a single diagnosis. New-onset neurologic (...) . Other organisms, such as the JC or SV40 viruses that cause PML, may be activated directly by HIV gene products. The likelihood of a particular neurologic syndrome correlates with the clinical stage of HIV infection as reflected by viral load, immune response, and CD4 + lymphocyte counts. This, in turn, is related to the severity of immunodeficiency and autoimmunity and to serum and tissue cytokine levels. Entrance of HIV into the CNS occurs early in the course of infection, likely within days

2014 eMedicine.com

28. HIV-1 Associated Opportunistic Infections: CNS Toxoplasmosis (Diagnosis)

study in Mexico city with 320 patients AIDS patients, the main conditions related to HIV/AIDS were brain toxoplasmosis (42%), cerebral cryptococcosis (28%), tuberculous meningitis (8.7%), lymphoma (non-Hodgkin) (3.75%), acute HIV infection (3.4%), and AIDS dementia complex (3%). [ ] The widespread use of antiretroviral treatment has decreased the incidence of toxoplasmic encephalitis. As an example, among HIV-infected patients in the United States, the annual number of toxoplasmosis-related (...) with sustained response to anti-retroviral therapy. Clin Microbiol Infect . 2006 Jul. 12(7):666-71. . Behbahani R, Moshfeghi M, Baxter JD. Therapeutic approaches for AIDS-related toxoplasmosis. Ann Pharmacother . 1995 Jul-Aug. 29(7-8):760-8. . AAN Quality Standards Subcommittee. Evaluation and management of intracranial mass lesions in AIDS. Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology . 1998 Jan. 50(1):21-6. . Klepser ME, Klepser TB. Drug treatment of HIV

2014 eMedicine.com

29. HIV-1 Associated CNS Complications (Diagnosis) (Diagnosis)

, neoplastic processes secondary to immunodeficiency or those related to treatment include: Immune Reconstitution Inflammatory Syndrome of the CNS (CNS-IRIS) [ , ] Kaposi sarcoma Fungal infections (eg, , Penicillium marneffei encephalitis) [ ] Tuberculous meningitis encephalitis In addition, HIV-infected patients are susceptible to the same neurologic diseases as patients without infection. In AIDS, a clinical presentation often cannot be explained with a single diagnosis. New-onset neurologic (...) . Other organisms, such as the JC or SV40 viruses that cause PML, may be activated directly by HIV gene products. The likelihood of a particular neurologic syndrome correlates with the clinical stage of HIV infection as reflected by viral load, immune response, and CD4 + lymphocyte counts. This, in turn, is related to the severity of immunodeficiency and autoimmunity and to serum and tissue cytokine levels. Entrance of HIV into the CNS occurs early in the course of infection, likely within days

2014 eMedicine.com

30. HIV-1 Associated Cerebrovascular Complications (Diagnosis)

, neoplastic processes secondary to immunodeficiency or those related to treatment include: Immune Reconstitution Inflammatory Syndrome of the CNS (CNS-IRIS) [ , ] Kaposi sarcoma Fungal infections (eg, , Penicillium marneffei encephalitis) [ ] Tuberculous meningitis encephalitis In addition, HIV-infected patients are susceptible to the same neurologic diseases as patients without infection. In AIDS, a clinical presentation often cannot be explained with a single diagnosis. New-onset neurologic (...) . Other organisms, such as the JC or SV40 viruses that cause PML, may be activated directly by HIV gene products. The likelihood of a particular neurologic syndrome correlates with the clinical stage of HIV infection as reflected by viral load, immune response, and CD4 + lymphocyte counts. This, in turn, is related to the severity of immunodeficiency and autoimmunity and to serum and tissue cytokine levels. Entrance of HIV into the CNS occurs early in the course of infection, likely within days

2014 eMedicine.com

31. HIV-1 Associated Cerebrovascular Complications (Treatment)

, neoplastic processes secondary to immunodeficiency or those related to treatment include: Immune Reconstitution Inflammatory Syndrome of the CNS (CNS-IRIS) [ , ] Kaposi sarcoma Fungal infections (eg, , Penicillium marneffei encephalitis) [ ] Tuberculous meningitis encephalitis In addition, HIV-infected patients are susceptible to the same neurologic diseases as patients without infection. In AIDS, a clinical presentation often cannot be explained with a single diagnosis. New-onset neurologic (...) . Other organisms, such as the JC or SV40 viruses that cause PML, may be activated directly by HIV gene products. The likelihood of a particular neurologic syndrome correlates with the clinical stage of HIV infection as reflected by viral load, immune response, and CD4 + lymphocyte counts. This, in turn, is related to the severity of immunodeficiency and autoimmunity and to serum and tissue cytokine levels. Entrance of HIV into the CNS occurs early in the course of infection, likely within days

2014 eMedicine.com

32. Efficacy of Riluzole in Surgical Treatment for Cervical Spondylotic Myelopathy (CSM-Protect)

Efficacy of Riluzole in Surgical Treatment for Cervical Spondylotic Myelopathy (CSM-Protect) Efficacy of Riluzole in Surgical Treatment for Cervical Spondylotic Myelopathy (CSM-Protect) - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more (...) studies before adding more. Efficacy of Riluzole in Surgical Treatment for Cervical Spondylotic Myelopathy (CSM-Protect) (CSM-Protect) The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our for details. ClinicalTrials.gov Identifier: NCT01257828 Recruitment Status : Completed First Posted : December 10, 2010 Last Update Posted : November 2, 2018 Sponsor

2010 Clinical Trials

33. Assessment of balance disorders

syndrome) Spinal cord trauma Guillain-Barre syndrome (GBS), polyradiculopathy Spinal spondylosis Spinal cord tumour Neuromyelitis optica (NMO) Subacute combined degeneration of the cord Syphilis, tabes dorsalis TB (Pott's disease) HIV infectious myelopathy Human T-lymphotrophic virus (HTLV)-1 infectious myelopathy SLE inflammatory myelopathy Anxiety disorder Drug toxicity Contributors Authors Instructor in Otology and Laryngology Harvard Medical School Boston MA Disclosures AP declares that he has (...) ). Dizziness and balance difficulty may also result from psychiatric disease, especially panic or anxiety disorders. However, patients with vestibular disorders also have a higher prevalence of panic and anxiety disorders. It is also important to consider that the cause of the balance disorder may be multifactorial. For example, a chronic alcoholic may have problems with balance due to alcohol-related neuropathy, alcohol-related cerebellar degeneration, and bilateral vestibulopathies from thiamine

2018 BMJ Best Practice

34. Guideline for the management of adults with Systemic Lupus Erythematosus (Full text)

treatment should be guided by a diagnostic renal biopsy. Immunosuppressive agents are recommended in class III A or III A/C (±V) and IV A or IV A/C (±V) nephritis, and also in pure class V nephritis if proteinuria exceeds 1 g/24 h despite the optimal use of renin–angiotensin–aldosterone system blockers. 3.2 The ultimate goals of treatment in LN are long-term preservation of renal function, prevention of disease flares, avoidance of treatment-related harms and improved quality of life and survival (...) in pure class V nephritis if proteinuria exceeds 1 g/24 h despite the optimal use of renin–angiotensin–aldosterone system blockers. 3.2 The ultimate goals of treatment in LN are long-term preservation of renal function, prevention of disease flares, avoidance of treatment-related harms and improved quality of life and survival. Treatment should aim for complete renal response with UPCR <50 mg/mol and normal or near-normal (within 10% of normal GFR if previously abnormal) renal function. Partial renal

2017 British Society for Rheumatology PubMed

35. BSR guideline Management of Adults with Primary Sjögren's Syndrome (Full text)

pathology other than SS including sarcoidosis, IgG4 disease [ ] and graft vs host disease [ ] may be implicated. Salivary gland aplasia and ductal atresia [ ] are both rare causes of oral sicca and viral infections including hepatitis C and HIV can cause salivary gland disease with hypertrophy and sicca symptoms. Xerostomia can be a feature of oral dysaesthesias with no objective reduction in salivary flow rate. Oral dysaesthesia or burning mouth syndrome is a chronic pain condition currently classified (...) Academy of Ophthalmologists reviewed the evidence for the oral antibiotics doxycycline, minocycline and azithromycin in the management of ocular surface disease arising from disorders of the meibomian glands. They identified eight studies that documented an improvement in meibomian gland-related ocular surface disease after treatment with these agents, although side effects were common. Only one study was a randomized, controlled trial. They concluded oral antibiotics may be an effective treatment

2017 British Society for Rheumatology PubMed

36. CRACKCast E108 – Neuromuscular Disorders

= Moves but unable to resist gravity 1 = Flicker but no movement 0 = No movement [3] Compare myelopathy, motor neuron disease, neuropathy, neuromuscular junction disease, and myopathy with respect to history, strength, DTR’s, sensation and muscle wasting. Clinical Characteristics of Neuromuscular Diseases (Table 98.1) Disease History Strength DTR Sensation Wasting Myelopathy Trauma, infection, cancer Normal to decreased Increased Normal to Decreased No Motor neuron disease (ALS) Progressive difficulty (...) swallowing, speaking, walking Decreased Increased Normal Yes Neuropathy Recent infection, ascending weakness Normal or decreased, distal>proximal Decreased Decreased Yes Neuromuscular junction disease Food (canned goods), Tick exposure, easy fatigability Normal to fatigue Normal Normal No Myopathy Thyroid disease, previous similar episodes Decreased, proximal>distal Normal Normal Yes [4] List 6 myelopathies, 1 motor neuron diseases, 4 neuropathies, 4 diseases of the NMJ, and 5 myopathies. Myelopathies

2017 CandiEM

37. Management of Chronic Pain in Survivors of Adult Cancers

peripheral neuropathy Raynaud’s syndrome Hormonal therapy–related pain syndromes Arthralgias Dyspareunia Gynecomastia Myalgias Osteoporotic compression fractures Radiation-related pain syndromes Chest wall syndrome Cystitis Enteritis and proctitis Fistula formation Lymphedema Myelopathy Osteoporosis Osteoradionecrosis and fractures Painful secondary malignancies Peripheral mononeuropathies Plexopathies: brachial, sacral Stem-cell transplantation–mediated graft-versus-host disease Arthralgias/myalgias (...) should be assessed. Clinicians should clearly understand terminology such as tolerance, dependence, abuse, and addiction as it relates to the use of opioids and should incorporate universal precautions to minimize abuse, addiction, and adverse consequences. Additional information is available at and . INTRODUCTION Section: As a result of extraordinary advancements in diagnosis and treatment, approximately 14 million individuals with a history of cancer (excluding nonmelanomatous skin cancers

2016 American Society of Clinical Oncology Guidelines

38. Acute Pain Management: Scientific Evidence

( Vernooij 2014 GL). As in the third edition, an indication of how the key messages in this fourth edition relate to those in the third edition is provided. An adapted version of the system used by Johnston et al (Johnston 2003) to reflect the implications of new evidence on clinical recommendations was therefore used as previously. Where the new evidence led to reversal of a conclusion and key message, this was noted in the text.x Acute Pain Management: Scientific Evidence Review and revision of key (...) ACUTE PAIN MANAGEMENT 53 3.1 Education 53 3.1.1 Patients 53 3.1.2 Staff 56 3.2 Organisational requirements 58 3.2.1 General requirements 59 3.2.2 Acute pain services 59 3.3 Economic considerations in acute pain management 62 3.3.1 Economic evaluation of patient-controlled analgesia 63 3.3.2 Economic evaluation of acute pain services 63 3.3.3 Economic benefit related to improved patient outcomes 64 References 64 4. ANALGESIC MEDICINES 69 4.1 Opioids 69 4.1.1 Systemic opioids 69 4.1.2 Neuraxial

2015 Clinical Practice Guidelines Portal

39. Hepatic Encephalopathy

, hepatic encephalopathy; HM, hepatic myelopathy; ICT, Inhibitory Control Test; ISHEN, International Society for Hepatic Encephalopathy and Nitrogen Metabolism; IV, intravenous; LOLA, L-ornithine L-aspartate; LT, Liver transplantation; MHE, minimal HE; MR, magnetic resonance; OHE, overt HE; PH, por- tal hypertension; PHES, Psychometric Hepatic Encephalopathy Score; PP , portal pressure; PSE, portosystemic encephalopathy; PSS, portosystemic shunting; RCT, randomized, controlled trial; TIPS, transjugular (...) , on brain functioning. The alterations of brain functioning, which can produce behavioral, cognitive, and motor effects, were termed portosystemic ence- phalopathy (PSE) 3 and later included in the term HE. 4 Unless the underlying liver disease is successfully treated, HE is associated with poor survival and a high risk of recurrence. 5,6 Even in its mildest form, HE reduces health-related quality of life and is a risk factor for bouts of severe HE. 7-9 Definition of HE Hepatic encephalopathy is a brain

2014 American Association for the Study of Liver Diseases

40. Family Practice Notebook Updates 2018

(hemeonc, pharm) May be used for vascular prevention (CAD or PAD) by adding 2.5 mg twice daily added to 81 mg in stable chronic CAD or PAD However, NNT 71 for serious CAD related event, NNT 147 for PAD related amputation and the NNH 80 to cause one major bleeding event (id, immunize, virus) As of 2018, is approved for use in 27-45 year old women and men at risk (rheum, cv) Avoid s and consider vasodilators (e.g. , , or in refractory cases, ) (er, pharm, toxin) Expect to see it in toothpaste, mouthwash (...) through the anterior, middle and posterior l body, that typically requires surgical repair Associated with cord injury, aorta injury, liver , and mesentary and injury (ortho, peds, c-spine) New radiculopathy or myelopathy (hyperreflexia, , babinski, weakness), esp. if bilateral, requires MRI prior to discharge (even if negative CT) MRI for ligamentous instability with subluxation, , l XI. Updates: March 2018 (pharm, nutrition) Healthy Kitchens, Healthy Lives conferences emphasizes delicious, plant

2019 FP Notebook

To help you find the content you need quickly, you can filter your results via the categories on the right-hand side >>>>